These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24475876)

  • 1. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women.
    Greer LT; Rosman M; Charles Mylander W; Liang W; Buras RR; Chagpar AB; Edwards MJ; Tafra L
    Breast J; 2014; 20(2):147-53. PubMed ID: 24475876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
    Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
    Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.
    Yoshihara E; Smeets A; Laenen A; Reynders A; Soens J; Van Ongeval C; Moerman P; Paridaens R; Wildiers H; Neven P; Christiaens MR
    Breast; 2013 Jun; 22(3):357-61. PubMed ID: 23022046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and predictors of axillary lymph node metastases in invasive breast cancer.
    Chua B; Ung O; Taylor R; Boyages J
    ANZ J Surg; 2001 Dec; 71(12):723-8. PubMed ID: 11906387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.
    Park SH; Kim EK; Park BW; Kim SI; Moon HJ; Kim MJ
    Ultraschall Med; 2013 Dec; 34(6):559-67. PubMed ID: 23258771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
    Chua B; Ung O; Taylor R; Boyages J
    ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases.
    Meretoja TJ; Audisio RA; Heikkilä PS; Bori R; Sejben I; Regitnig P; Luschin-Ebengreuth G; Zgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Kővári B; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Jensen MB; Cserni G; Leidenius MH
    Breast Cancer Res Treat; 2013 Apr; 138(3):817-27. PubMed ID: 23558360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
    Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
    Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of axillary lymphatic spread in triple-negative breast cancer.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Breast Cancer Res Treat; 2015 Jan; 149(1):229-36. PubMed ID: 25488719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.